A systematic review and meta-analysis of tumor necrosis factor -308 polymorphism and Kawasaki disease

Pediatrics International

Volumn 52, Issue 4, 2010, Pages 527-532

  Arj Ong, Sakda ^a   Thakkinstian, Ammarin ^a   McEvoy, Mark ^b   Attia, John ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

genetic association studies; Kawasaki disease; meta analysis; tumor necrosis factor alpha 308

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA 308; UNCLASSIFIED DRUG;

ALLELE; CLINICAL TRIAL; EMBASE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

GENE FREQUENCY; GENOTYPE; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955785918     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03105.x     Document Type: Review

References (47)

1. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J. Pediatr. 1975 86 : 892 8.
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974 54 : 271 6.
3. Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the United States. Am. J. Dis. Child. 1976 130 : 599 607.
4. Morens DM, Anderson LJ, Hurwitz ES. National surveillance of Kawasaki disease. Pediatrics 1980 65 : 21 5.
5. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch. Pediatr. Adolesc. Med. 1995 149 : 779 83.
6. Abe J, Kotzin BL, Jujo K et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc. Natl. Acad. Sci. U. S. A. 1992 89 : 4066 70.
7. Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986 320 : 584 8.
8. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993 342 : 1385 8.
9. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994 371 : 508 10.
10. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit. Care Med. 1996 24 : 381 4.
11. Lin CY, Hwang B. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease). Ann. Allergy 1987 59 : 291 7.
12. Fildes N, Burns JC, Newburger JW, Klitz W, Begovich AB. The HLA class II region and susceptibility to Kawasaki disease. Tissue Antigens 1992 39 : 99 101.
13. Kato S, Kimura M, Tsuji K et al. HLA antigens in Kawasaki disease. Pediatrics 1978 61 : 252 5.
14. Krensky AM, Berenberg W, Shanley K, Yunis EJ. HLA antigens in mucocutaneous lymph node syndrome in New England. Pediatrics 1981 67 : 741 3.
15. Krensky AM, Grady S, Shanley KM, Berenberg W, Yunis EJ. Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome. Hum. Immunol. 1983 6 : 75 7.
16. Furukawa S, Matsubara T, Jujoh K et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin. Immunol. Immunopathol. 1988 48 : 247 51.
17. Hui-Yuen JS, Duong TT, Yeung RS. TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J. Immunol. 2006 176 : 6294 301.
18. Lang BA, Silverman ED, Laxer RM, Lau AS. Spontaneous tumor necrosis factor production in Kawasaki disease. J. Pediatr. 1989 115 : 939 43.
19. Lin CY, Lin CC, Hwang B, Chiang BN. The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease. Eur. J. Pediatr. 1991 150 : 179 82.
20. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin. Immunol. Immunopathol. 1990 56 : 29 36.
21. Maury CP, Salo E, Pelkonen P. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J. Lab. Clin. Med. 1989 113 : 651 4.
22. Sakaguchi M, Kato H, Nishiyori A, Sagawa K, Itoh K. Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): Preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells. Clin. Exp. Immunol. 1995 99 : 276 82.
23. Sato N, Sagawa K, Sasaguri Y, Inoue O, Kato H. Immunopathology and cytokine detection in the skin lesions of patients with Kawasaki disease. J. Pediatr. 1993 122 : 198 203.
24. Stringer E, Yeung R. Pathogenesis of Kawasaki disease: The central role of TNF-. Future Rheumatol. 2008 3 : 69 77.
25. Leung DY, Collins T, Lapierre LA, Geha RS, Pober JS. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J. Clin. Invest. 1986 77 : 1428 35.
26. Leung DY, Geha RS, Newburger JW et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J. Exp. Med. 1986 164 : 1958 72.
27. Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med. J. 2003 44 : 1021 6.
28. Cheung YF, Huang GY, Chen SB et al. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 2008 122 : e608 614.
29. Chien YH, Chang KW, Yang YH, Lu MY, Lin YT, Chiang BL. Association between levels of TNF-alpha and TNF-alpha promoter -308 A/A polymorphism in children with Kawasaki disease. J. Formos. Med. Assoc. 2003 102 : 147 50.
30. Kamizono S, Yamada A, Higuchi T, Kato H, Itoh K. Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease. Pediatr. Int. 1999 41 : 341 5.
31. Quasney MW, Bronstein DE, Cantor RM et al. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr. Res. 2001 49 : 686 90.
32. Yang J, Li CR, Li YB et al. [The correlation between Kawasaki disease and polymorphisms of tumor necrosis factor alpha and interleukin-10 gene promoter Zhonghua Er Ke Za Zhi 2003 41 : 598 602 (in Chinese).
33. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin. Exp. Immunol. 1998 113 : 401 6.
34. Nedwin GE, Naylor SL, Sakaguchi AY et al. Human lymphotoxin and tumor necrosis factor genes: Structure, homology and chromosomal localization. Nucl. Acids Res. 1985 13 : 6361 73.
35. Onouchi Y. Molecular genetics of Kawasaki disease. Pediatr. Res. 2009 65 : 46R 54R.
36. Thakkinstian A, McEvoy M, Minelli C et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: A HuGE review. Am. J. Epidemiol. 2005 162 : 201 11.
37. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003 327 : 557 60.
38. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 : 629 34.
39. Egger M, Smith G, Altman D. Systematic Reviews in Health Care: Meta-Analysis in Context. BMJ Publishing Group
40. Hirono K, Foell D, Xing Y et al. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease. J. Am. Coll. Cardiol. 2006 48 : 1257 64.
41. Kaneko M, Ono T, Matsubara T et al. Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning. Microbiol. Immunol. 2004 48 : 703 11.
42. Langen H, von Kietzell D, Byrd D et al. Renal polyamine excretion, tubular amino acid reabsorption and molecular genetics in cystinuria. Pediatr. Nephrol. 2000 14 : 376 84.
43. Lau AC, Duong TT, Ito S, Yeung RS. Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease. Arthritis Rheum. 2008 58 : 854 63.
44. Nishimura S, Zaitsu M, Hara M et al. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J. Pediatr. 2003 143 : 357 62.
45. Yoshida LS, Tsunawaki S. Expression of NADPH oxidases and enhanced H(2)O(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha. Int. Immunopharmacol. 2008 8 : 1377 85.
46. Takeshita S, Nakatani K, Tsujimoto H, Kawamura Y, Kawase H, Sekine I. Increased levels of circulating soluble CD14 in Kawasaki disease. Clin. Exp. Immunol. 2000 119 : 376 81.
47. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J. Exp. Med. 1993 177 : 557 60.